✦ LIBER ✦

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

✍ Scribed by Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietzsch; Peter A. Maubach; Helmut Lambertz; Daniel Oruzio; Rudolf Schlag; Karin Weigang-Köhler; Ute Vehling-Kaiser; Manfred Schulze; Juergen Truckenbrodt; Mariele Goebeler; Johann Mittermüller; Daniel Bosse; Borika Szukics; Marc Grundeis; Thomas Zwingers; Clemens Giessen; Volker Heinemann

Book ID: 116430555
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 391 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.09.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin plus irinotecan promising as

Oxaliplatin plus irinotecan promising as first-line treatment for advanced colorectal cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Cost-effectiveness analysis of irinoteca

Cost-effectiveness analysis of irinotecan plus fluorouracil/folinic acid compared with fluorouracil/folinic acid alone as first-line treatment for advanced colorectal cancer

✍ Warren Mark Hart; Carlos Rubio-Terrés; Linda Pronk; Svetlana Kobina; Eduardo Día 📂 Article 📅 2003 🏛 Springer Milan 🌐 Spanish ⚖ 188 KB

Irinotecan (CPT-11) plus oxaliplatin (LO

Irinotecan (CPT-11) plus oxaliplatin (LOHP) plus infusional 5-fluorouracil (5-FU) and leukovorin (LV) as first line treatment for metastatic colorectal cancer (MCC): A phase II trial

✍ Souglakos, J.; Kakolyris, S.; Athanasiadis, A.; Kouroussis, Ch.; Mavroudis, D.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

598 ORAL Randomised comparison of 5-FU/f

598 ORAL Randomised comparison of 5-FU/folinic acid plus irinotecan (FOLFIRI) and irinotecan plus oxaliplatin (IROX) in first-line therapy of metastatic colorectal cancer (CRC): the fire-trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Irinotecan plus folinic acid/continuous

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

✍ Andreas Teufel; Silke Steinmann; Jürgen Siebler; Christiane Zanke; Herbert Hohl; 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 301 KB